Isuprel (Cardinal Health)


Welcome to the PulseAid listing for the Isuprel drug offered from Cardinal Health. This Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Cardinal Health
NON-PROPRIETARY NAME: ISOPROTERENOL HYDROCHLORIDE
SUBSTANCE NAME: ISOPROTERENOL HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC]
ROUTE: INTRACARDIAC; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2012-06-18
END MARKETING DATE: 0000-00-00


Isuprel HUMAN PRESCRIPTION DRUG Details:

Item DescriptionIsuprel from Cardinal Health
LABELER NAME: Cardinal Health
DEA SCHEDULE:
ACTIVE STRENGTH: 0.2(mg/mL)
START MARKETING DATE: 2012-06-18
END MARKETING DATE: 0000-00-00
PRODUCT ID: 55154-4729_7db5c78c-0463-4ec9-b237-33f13e2f6460
PRODUCT NDC: 55154-4729
APPLICATION NUMBER: NDA010515

Other ISOPROTERENOL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cardinal HealthIsuprel
Hospira, Inc.Isuprel
Nexus Pharmaceuticals IncIsoproterenol Hydrochloride
Valeant Pharmaceuticals North America LLCIsuprel